134 related articles for article (PubMed ID: 2041166)
21. [A case of primary malignant lymphoma of the bladder].
Nishida S; Kuroko K; Hoshino T; Iwamoto T; Shirai C
Hinyokika Kiyo; 1998 Aug; 44(8):599-601. PubMed ID: 9783199
[TBL] [Abstract][Full Text] [Related]
22. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
23. Alternating chemotherapy of CHOP-Bleo and POEM-Bleo for diffuse large-cell lymphoma: a single-institutional study with a long-term follow-up.
Ohnoshi T; Hayashi K; Ueno K; Tada A; Mizuta J; Tagawa S; Matsutomo S; Saito S; Kawashima K; Yoshino T
Int J Hematol; 1993 Aug; 58(1-2):93-8. PubMed ID: 7693030
[TBL] [Abstract][Full Text] [Related]
24. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
Ise M; Sakai C; Kumagai K
Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
[TBL] [Abstract][Full Text] [Related]
25. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
26. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
27. Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma.
Niitsu N; Okamoto M; Aoki S; Okumura H; Yoshino T; Miura I; Hirano M
Ann Hematol; 2006 Jun; 85(6):374-80. PubMed ID: 16518603
[TBL] [Abstract][Full Text] [Related]
28. [Complete remission of plasmablastic IgD lambda multiple myeloma induced by continuous infusion of low-dose cytarabine and etoposide].
Fukuno K; Tsurumi H; Yamada T; Oyama M; Moriwaki H
Rinsho Ketsueki; 2000 Jun; 41(6):513-8. PubMed ID: 10921352
[TBL] [Abstract][Full Text] [Related]
29. CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma.
Czuczman MS
Semin Oncol; 1999 Oct; 26(5 Suppl 14):88-96. PubMed ID: 10561023
[TBL] [Abstract][Full Text] [Related]
30. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
Cheung NK; Kushner BH; LaQuaglia M; Kramer K; Gollamudi S; Heller G; Gerald W; Yeh S; Finn R; Larson SM; Wuest D; Byrnes M; Dantis E; Mora J; Cheung IY; Rosenfield N; Abramson S; O'Reilly RJ
Med Pediatr Oncol; 2001 Jan; 36(1):227-30. PubMed ID: 11464891
[TBL] [Abstract][Full Text] [Related]
31. Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia.
Goldschmidt N; Gural A; Kornberg A; Spectre G; Shopen A; Paltiel O
Am J Hematol; 2004 Aug; 76(4):364-7. PubMed ID: 15282670
[TBL] [Abstract][Full Text] [Related]
32. Histiocytic sarcoma with secondary involvement of the skin and expression of CD1a: evidence of indeterminate cell differentiation?
Frater JL; Kling CW; Obadiah JM; Gardner LJ; Grosso LE; Resh B; Hurley MY
J Cutan Pathol; 2006 Jun; 33(6):437-42. PubMed ID: 16776720
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
34. [Malignant lymphoma of the penis: report of two cases].
Kuwahara Y; Kubota Y; Hibi H; Yanaoka Y; Okishio N; Hoshinaga K; Naide Y; Kasahara M
Hinyokika Kiyo; 1997 May; 43(5):371-4. PubMed ID: 9208325
[TBL] [Abstract][Full Text] [Related]
35. [A malignant lymphoma (non-hodgkin lymphoma, follicular type) patient who achieved complete remission by radiochemotherapy].
Tanaka T; Araki T; Kasuya G; Fujino T; Makita K
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1931-4. PubMed ID: 19920404
[TBL] [Abstract][Full Text] [Related]
36. [Two cases of orbital non-Hodgkin's lymphoma presenting with hemophagocytic syndrome].
Hara T; Tsurumi H; Yoshimura K; Takenaka K; Goto H; Tajika M; Sawada M; Murakami N; Moriwaki H
Rinsho Ketsueki; 2000 Jan; 41(1):48-53. PubMed ID: 10695399
[TBL] [Abstract][Full Text] [Related]
37. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of cytophagic histiocytic panniculitis with modified CHOP-E. Cyclophosphamide, adriamycin, vincristine, predonisone, and etoposide.
Matsue K; Itoh M; Tsukuda K; Miyazaki K; Kokubo T
Am J Clin Oncol; 1994 Dec; 17(6):470-4. PubMed ID: 7977162
[TBL] [Abstract][Full Text] [Related]
39. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
[No Abstract] [Full Text] [Related]
40. [A case of retroperitoneal malignant lymphoma successfully treated by chemotherapy].
Nakao A; Kamada K; Imamura M; Sakagami K; Uda M; Mitsuoka S; Ito H
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1599-602. PubMed ID: 9725055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
